AA
TYRA icon

ALPS Advisors’s Tyra Biosciences TYRA Stock Holding History

ALPS Advisors’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.68M Buy
43,856
+29
+0.1% +$939 0.01% 439
2025
Q4 		$1.15M Buy
43,827
+19,127
+77% +$351K 0.01% 520
2025
Q3 		$346K Sell
24,700
-4,029
-14% -$45.9K ﹤0.01% 937
2025
Q2 		$275K Buy
+28,729
New +$273K ﹤0.01% 954

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

ALPS Advisors's TYRA Position: Q1 2026 in Review

ALPS Advisors increased its Tyra Biosciences (TYRA) stake by 0.07% in Q1 2026, buying an estimated $939 and bringing the position to 43,856 shares worth $1.68M. The position accounts for 0.01% of the portfolio, ranked #439.

ALPS Advisors first reported a position in TYRA in Q2 2025 and has held it in 4 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • ALPS Advisors held 43,856 shares of Tyra Biosciences worth $1.68M as of Q1 2026.
  • ALPS Advisors bought 29 Tyra Biosciences shares in Q1 2026, an estimated $939.
  • Tyra Biosciences made up 0.01% of ALPS Advisors's portfolio in Q1 2026, its #439 holding.
  • ALPS Advisors first reported a position in Tyra Biosciences in Q2 2025 and has held it in 4 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on ALPS Advisors's 13F filing for Q1 2026, filed 8 May 2026.